Analysis of Immune Responses to HIV Vaccines

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

NCT00058734 ·Status: COMPLETED ·Phase: PHASE1

HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

NCT00056758 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

NCT00006578 ·Status: WITHDRAWN ·Phase: NA

Study of Anti-HIV Therapy Intensification

NCT00034086 ·Status: COMPLETED ·Phase: NA

Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials

NCT01376726 ·Status: COMPLETED ·Phase: PHASE1

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

NCT00056797 ·Status: COMPLETED ·Phase: PHASE2

Resistance to HIV Infection

NCT00069485 ·Status: UNKNOWN

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756 ·Status: COMPLETED ·Phase: PHASE1

Umbrella Study for HIV Infected Adults Enrolled in NIAID-Funded Interleukin-2 Studies

NCT00311688 ·Status: COMPLETED

Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer

NCT00968630 ·Status: COMPLETED ·Phase: PHASE2

Safety of and Immune Response to an Experimental HIV Vaccine (VRC-HIVADV014-00-VP) in HIV Uninfected Adults

NCT00119873 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects

NCT00833781 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of Cytotoxic T Lymphocyte (CTL) Therapy in HIV-Infected Patients

NCT00000824 ·Status: TERMINATED ·Phase: NA

Screening HIV-Infected Patients for Vaccine Studies

NCT00051519 ·Status: COMPLETED

Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

NCT05115838 ·Status: WITHDRAWN ·Phase: PHASE2

N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV

NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

NCT00021762 ·Status: WITHDRAWN ·Phase: PHASE2

Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines

NCT00001210 ·Status: COMPLETED

A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3

NCT00001064 ·Status: TERMINATED ·Phase: NA

A Study of HIV in Newly Infected Individuals

NCT00000930 ·Status: COMPLETED

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy Adults

NCT00695877 ·Status: COMPLETED ·Phase: PHASE1

Immune Responses to Two Experimental HIV Vaccines in Healthy Adults

NCT01386489 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Trial of Vaccine Therapy of HIV-1 Infected Individuals With 50-500 CD4 Cells/mm3

NCT00000755 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

NCT00076037 ·Status: COMPLETED ·Phase: PHASE1